1. Home
2. COVID-19/SARS-CoV-2

COVID-19/SARS-CoV-2

• Treatment guidelines.
  • "Interim clinical guidance for patients  with suspected or confirmed COVID-19 in Belgium"  (these recommendations may be subject to modifications, this link always leads to the most recent version).
  • Composition of the working group that drafted the Belgian guidelines (click on the names to see possible "conflicts of interest"):                                                    Koen BLOT: Department of Epidemiology and Public Health, Sciensano (Brussels).
    Emmanuel BOTTIEAU: Department  of Clinical Sciences, Instituut voor Tropische Geneeskunde [ITG (Antwerp)].
    Nicolas DAUBY: Department of Internal Medicine and Infectious Diseases, CHU-Saint-Pierre (Brussels).
    Julien DE GREEF: Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc-UCLouvain (sint-Lambrechts-Woluwe).
    Pieter DEPUYDT: Department of Intensive Care Medicine, UZ Gent (Ghent).
    Paul DE MUNTER: Department of Internal Medicine, UZ Leuven (Leuven).
    Maya HITES: Department of Infectious Diseases, Cliniques Universitaires de Bruxelles [CUB-Erasme (Anderlecht)].
    Patrick LACOR: Department of Internal Medicine, UZ Brussel (Jette).
    Natalie LORENT: Department of Pneumology, UZ Leuven (Leuven).
    Jiska MALOTAUX: Department of Internal Medicine, UZ Gent (Ghent).
    Fabio TACCONE: Department of  of Intensive Care Medicine, Cliniques Universitaires de Bruxelles [CUB-Erasme (Anderlecht)].
    Caroline THEUNISSEN: Department of Clinical Sciences, [ITG (Antwerp)].
    Eva VAN BRAECKEL: Department of Respiratory Medicine, UZ Gent (Ghent).
    Sabrina VAN IERSSEL: Department of Internal Medicine, UZ Antwerpen (Edegem).
    Roel VAN LOOCK: DG PRE – Department of Assessors: FAGG - AFMPS (Brussels).
    Sandrine MILAS: Department of Infectious Diseases CHU Charleroi (Charleroi).
  • "Richtlijnen voor de behandeling van kinderen met COVID-19" [guidelines of the UZ Leuven, revised in an independent way by the Belgian COVID-19 Paedia-tric Task Force (in Dutch)].
  • "Recommandations pour le traitement des enfants atteints de COVID-19" [guidelines of the UZ Leuven, revised in an independent way by the Belgian Pae-diatric Covid-19 Task Force (in French)].
    

• Mandatory reporting forms for the admission and discharge to and from the hospital of patients with COVID-19.
  • Admission form: word version in Dutch.
  • Admission form: electronic version in Dutch.
  • Discharge form: word version in Dutch.
  • Discharge form: electronic version in Dutch.
    
  • Admission form: word version in French.
  • Admission form: electronic version in French.
  • Discharge form: word version word in French.
  • Discharge form: electronic version in French.

• General information concerning COVID-19/SARS-CoV-2 can be obtained from:
  • Sciensano.
  • the Belgian Federal Public Service (FPS) Health .
  • the Belgian Group of Paediatricians-Infectiologists.
  • the Belgian Federal Agency for Medicines and Health Products (FAMHP).
    
  • the Belgian Centre for Pharmaceutical Information [BCFI (Dutch version)] .
  • the Belgian Centre for Pharmaceutical Information [CBIP (French version)].
    
  • the European Centre for Disease Prevention and Control (ECDC).
  • the Centers for Disease Control and Prevention (CDC).
  • the Infectious Diseases Society of America (IDSA).
  • the National Institutes of Health (NIH).
  • the World Health Organization (WHO), regional office for Europe.
  • the Lancet.
  • the New England Journal of Medicine (NEJM).
  • the New England Journal of Medicine Watch (NEJM Journal Watch.

• "Database about all COVID-19 clinical trials running in Belgium which have been approved by FAMHP" (fill in covid-19 in the "medical condition/affection" case and click on "Apply" at the bottom of the page).

• Recommended reading.
  
  • "Pandemic preparedness plan for hospitals: part 1" [Nederlandse Vereniging voor Intensive Care (in Dutch)].
  • Ethical aspects and COVID-19.
    
    • "Ethical principles concerning the proportionality of critical care during the 2020 COVID-19 pandemic in Belgium" (Belgian Society of Intensive Care Medcine).
      
    • "Ethical aspects of making choices in the COVID-19 crisis" [guidelines UZ Leuven (in Dutch)].
  • COVID-19 and HIV infection.
    
    • "SARS-CoV-2: impact on people living with HIV (PLWH)" (guidelines Institute of Tropical Medicine, Antwerp).
    • "Updated EACS and BHIVA statement on risk of COVID-19 for people living with HIV (PLWH)".
  • "COVID-19: gastrointestinal manifestations and potential fecal-oral transmission" (pre proof publication in "Pharmacology").
  • "The internet book of critical care: COVID-19".
  • Pharmaceuticals for the treatment of COVID-19.
    
    • Use of convalescent plasma.
      • "The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study".
      • "Investigational COVI-19 convalescent plasma: emergency innovative new drugs".
      • "Development initiated for a plasma-derived COVID-19 therapy" (European Pharmaceutical Review).
    • "No azithromycin for the at home treatment of patients with COVID-19" (recommendations by the Belgian health authorities BAPCOC and FAGG/ AFMPS): in Dutch / in French.
    • "Coronavirus drugs already in the pipeline" (Yahoo Finance).
    • "Effective treatment of severe COVID-19 patients with tocilizumab (RoAcemtra)" (small Chinese trial).
    • "Tocilizumab safety profile" (FAGG-AFMPS).

• At home treatment of adult patients with community acquired bacterial pneumonia (IGGI recommendations).
  • Preliminary remarks, CAP subgroup I and CAP subgroup II (in Dutch).
  • Preliminary remarks, CAP subgroup I and CAP subgroup II (in French).